Viral-inhibiting apparatus and methods

Abstract

Apparatus and methodology are disclosed, which impose an electric current signal of reversing polarity between electrodes through viral-laden tissue.

1 - 18 . (canceled)  
   
   
       19 . A method of transcutaneously inhibiting viral phenomenon at a person's skin comprising the acts of: 
 externally applying a complex low amp current signal of a first polarity across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time;    reversing the first polarity and oppositely externally applying a low amp current signal to the viral-laden region between the electrodes for a second controlled interval of time;    first and second differential output circuits;    supplying the current signal between electrodes in the first polarity and reverse polarity from first and second differential output circuits, respectively;    subjecting the first and second differential output circuits to zero bias when off.    
   
   
       20 . A method of transcutaneously inhibiting viral phenomenon at a person's skin comprising the acts of: 
 externally applying a complex low amp current signal of a first polarity across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time;    reversing the first polarity and oppositely externally applying a low amp current signal to the viral-laden region between the electrodes for a second interval of time;    automatically terminating access to a low voltage source of electrical energy after a predetermined time of access, to conserve power.    
   
   
       21 . A method according to  claim 20  wherein access to the source of electrical energy is restored by human intervention.  
   
   
       22 . A method wherein of transcutaneously inhibiting viral phenomenon at a person's skin comprising the acts of: 
 externally applying a complex low amp current signal of a first polarity across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time;    reversing the first polarity and oppositely externally applying a low amp current signal to the viral-laden region between the electrodes for a second controlled interval of time;    using high gain amplification to drive the output current signals deep into subcutaneous tissue.    
   
   
       23 . A method according to  claim 22  wherein the high gain amplification is achieved by regenerating the signals delivered to the electrodes.  
   
   
       24 . A method of transcutaneously inhibiting viral phenomenon at a person's skin comprising the acts of: 
 externally applying a complex low amp current signal of a first polarity across a viral-laden region of the skin between spaced electrodes for a first controlled interval of time;    reversing the first polarity and oppositely externally applying a low amp current signal to the viral-laden region between the electrodes for a second controlled interval of time;    sensing the level of the output current signal;    providing a warning when the level exceeds a predetermined amount; and    disabling of the flow of current between electrodes.